News Releases

Date Title and Summary Additional Formats
Toggle Summary HTG Molecular Diagnostics Unveils New Direct-Target Sequencing Chemistry to Launch in First Quarter 2017
TUCSON, Ariz. , Feb. 27, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM)("HTG"), a provider of instruments, reagents and services for molecular profiling applications announced that its new direct-target sequencing chemistry will be available in the company’s VERI/O
View HTML
Toggle Summary HTG Molecular Diagnostics Completes Module Three Filing for HTG EdgeSeq ALKPlus Assay PMA
TUCSON, Ariz. , Jan. 05, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM) (“HTG”), a provider of instruments and reagents for molecular profiling applications, today announced that it has submitted to the FDA the third of four expected modules for the Company’s Pre-Market
View HTML
Toggle Summary HTG Molecular Diagnostics and QIAGEN Team Up to Advance Precision Diagnostics
TUCSON, Ariz. , and VENLO, the Netherlands , Nov. 16, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM) (“HTG”), a provider of instruments and reagents for molecular profiling applications and QIAGEN Manchester Limited , a wholly owned subsidiary of QIAGEN N.V.
View HTML
Toggle Summary HTG Molecular Diagnostics Reports Third Quarter 2016 Results
TUCSON, Ariz. , Nov. 14, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (NASDAQ:HTGM), a provider of instruments and reagents for molecular profiling applications, today reported financial results for the three and nine month periods ended September 30, 2016 .
View HTML
Toggle Summary HTG Molecular Diagnostics to Hold 2016 Third Quarter Financial Results Conference Call on November 14, 2016
TUCSON, Ariz. , Nov. 03, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced that the Company will release 2016 third quarter financial results after market close on Monday, November
View HTML
Toggle Summary HTG Molecular Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
TUCSON, Ariz. , Nov. 02, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced that its management will be presenting at the Canaccord Genuity Medical Technologies & Diagnostics Forum
View HTML
Toggle Summary UPDATE – HTG Molecular Diagnostics and Merck KGaA, Darmstadt, Germany, Enter Into a Master Companion Diagnostics Agreement
TUCSON, Ariz. , Oct. 11, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM) (“HTG”), a provider of instruments and reagents for molecular profiling applications, and Merck KGaA , Darmstadt, Germany , have entered a broad companion diagnostics master agreement.
View HTML
Toggle Summary HTG Molecular Diagnostics and Merck KGaA, Darmstadt, Germany, Enter Into a Master Companion Diagnostics Agreement
TUCSON, Ariz. , Oct. 11, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM) (“HTG”), a provider of instruments and reagents for molecular profiling applications, and Merck KGaA , Darmstadt, Germany , have entered a broad companion diagnostics master agreement.
View HTML
Toggle Summary Dr. Ann Hanham Joins HTG Molecular Diagnostics’ Board of Directors
TUCSON, Ariz. , Aug. 29, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq:HTGM), a provider of instruments and reagents for molecular profiling applications, today announced that Ann F. Hanham , Ph.D. has been appointed to its Board of Directors (“Board”).
View HTML
Toggle Summary HTG Molecular Diagnostics Reports Second Quarter 2016 Results
TUCSON, Ariz. , Aug. 09, 2016 (GLOBE NEWSWIRE) --   HTG Molecular Diagnostics , Inc. (NASDAQ:HTGM), a provider of instruments and reagents for molecular profiling applications, today reported financial results for the three and six month periods ended June 30, 2016 .
View HTML